These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 25215657)

  • 1. Forced IDO1 expression in dendritic cells restores immunoregulatory signalling in autoimmune diabetes.
    Pallotta MT; Orabona C; Bianchi R; Vacca C; Fallarino F; Belladonna ML; Volpi C; Mondanelli G; Gargaro M; Allegrucci M; Talesa VN; Puccetti P; Grohmann U
    J Cell Mol Med; 2014 Oct; 18(10):2082-91. PubMed ID: 25215657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chimeric Vaccine Stimulation of Human Dendritic Cell Indoleamine 2, 3-Dioxygenase Occurs via the Non-Canonical NF-κB Pathway.
    Kim NS; Mbongue JC; Nicholas DA; Esebanmen GE; Unternaehrer JJ; Firek AF; Langridge WH
    PLoS One; 2016; 11(2):e0147509. PubMed ID: 26881431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galectin 3 protects from cisplatin-induced acute kidney injury by promoting TLR-2-dependent activation of IDO1/Kynurenine pathway in renal DCs.
    Volarevic V; Markovic BS; Jankovic MG; Djokovic B; Jovicic N; Harrell CR; Fellabaum C; Djonov V; Arsenijevic N; Lukic ML
    Theranostics; 2019; 9(20):5976-6001. PubMed ID: 31534532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deficiency of immunoregulatory indoleamine 2,3-dioxygenase 1in juvenile diabetes.
    Orabona C; Mondanelli G; Pallotta MT; Carvalho A; Albini E; Fallarino F; Vacca C; Volpi C; Belladonna ML; Berioli MG; Ceccarini G; Esposito SM; Scattoni R; Verrotti A; Ferretti A; De Giorgi G; Toni S; Cappa M; Matteoli MC; Bianchi R; Matino D; Iacono A; Puccetti M; Cunha C; Bicciato S; Antognelli C; Talesa VN; Chatenoud L; Fuchs D; Pilotte L; Van den Eynde B; Lemos MC; Romani L; Puccetti P; Grohmann U
    JCI Insight; 2018 Mar; 3(6):. PubMed ID: 29563329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct roles of immunoreceptor tyrosine-based motifs in immunosuppressive indoleamine 2,3-dioxygenase 1.
    Albini E; Rosini V; Gargaro M; Mondanelli G; Belladonna ML; Pallotta MT; Volpi C; Fallarino F; Macchiarulo A; Antognelli C; Bianchi R; Vacca C; Puccetti P; Grohmann U; Orabona C
    J Cell Mol Med; 2017 Jan; 21(1):165-176. PubMed ID: 27696702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon-γ induces a tryptophan-selective amino acid transporter in human colonic epithelial cells and mouse dendritic cells.
    Bhutia YD; Babu E; Ganapathy V
    Biochim Biophys Acta; 2015 Feb; 1848(2):453-62. PubMed ID: 25450809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of indoleamine 2, 3-dioxygenase in human dendritic cells by a cholera toxin B subunit-proinsulin vaccine.
    Mbongue JC; Nicholas DA; Zhang K; Kim NS; Hamilton BN; Larios M; Zhang G; Umezawa K; Firek AF; Langridge WH
    PLoS One; 2015; 10(2):e0118562. PubMed ID: 25714914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indoleamine 2,3-dioxygenase: from catalyst to signaling function.
    Fallarino F; Grohmann U; Puccetti P
    Eur J Immunol; 2012 Aug; 42(8):1932-7. PubMed ID: 22865044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IDO1 and TGF-β Mediate Protective Effects of IFN-α in Antigen-Induced Arthritis.
    Chalise JP; Pallotta MT; Narendra SC; Carlsson B; Iacono A; Namale J; Boon L; Grohmann U; Magnusson M
    J Immunol; 2016 Oct; 197(8):3142-3151. PubMed ID: 27647832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolerogenic Phenotype of IFN-γ-Induced IDO+ Dendritic Cells Is Maintained via an Autocrine IDO-Kynurenine/AhR-IDO Loop.
    Li Q; Harden JL; Anderson CD; Egilmez NK
    J Immunol; 2016 Aug; 197(3):962-70. PubMed ID: 27316681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Relay Pathway between Arginine and Tryptophan Metabolism Confers Immunosuppressive Properties on Dendritic Cells.
    Mondanelli G; Bianchi R; Pallotta MT; Orabona C; Albini E; Iacono A; Belladonna ML; Vacca C; Fallarino F; Macchiarulo A; Ugel S; Bronte V; Gevi F; Zolla L; Verhaar A; Peppelenbosch M; Mazza EMC; Bicciato S; Laouar Y; Santambrogio L; Puccetti P; Volpi C; Grohmann U
    Immunity; 2017 Feb; 46(2):233-244. PubMed ID: 28214225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolerogenic Plasmacytoid Dendritic Cells Control Paracoccidioides brasiliensis Infection by Inducting Regulatory T Cells in an IDO-Dependent Manner.
    Araújo EF; Medeiros DH; Galdino NA; Condino-Neto A; Calich VL; Loures FV
    PLoS Pathog; 2016 Dec; 12(12):e1006115. PubMed ID: 27992577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The kinetics of plasmacytoid dendritic cell accumulation in the pancreas of the NOD mouse during the early phases of insulitis.
    Welzen-Coppens JM; van Helden-Meeuwsen CG; Leenen PJ; Drexhage HA; Versnel MA
    PLoS One; 2013; 8(1):e55071. PubMed ID: 23372814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of chimeric vaccine stimulation of indoleamine 2,3-dioxygenase biosynthesis in human dendritic cells is independent of TGF-β signaling.
    Esebanmen GE; Langridge WHR
    Cell Immunol; 2017 Sep; 319():43-52. PubMed ID: 28864263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Class IA PI3Ks regulate subcellular and functional dynamics of IDO1.
    Iacono A; Pompa A; De Marchis F; Panfili E; Greco FA; Coletti A; Orabona C; Volpi C; Belladonna ML; Mondanelli G; Albini E; Vacca C; Gargaro M; Fallarino F; Bianchi R; De Marcos Lousa C; Mazza EM; Bicciato S; Proietti E; Milano F; Martelli MP; Iamandii IM; Graupera Garcia-Mila M; Llena Sopena J; Hawkins P; Suire S; Okkenhaug K; Stark AK; Grassi F; Bellucci M; Puccetti P; Santambrogio L; Macchiarulo A; Grohmann U; Pallotta MT
    EMBO Rep; 2020 Dec; 21(12):e49756. PubMed ID: 33159421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral probiotic promotes indoleamine 2,3-dioxygenase- and TGF-β-Producing plasmacytoid dendritic cells to initiate protection against type 1 diabetes.
    Nelson AS; Akgul A; Maddaloni M; Bhagyaraj E; Hoffman C; Pascual DW
    Immunol Lett; 2021 Nov; 239():12-19. PubMed ID: 34333043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Proteasome Inhibitor Bortezomib Controls Indoleamine 2,3-Dioxygenase 1 Breakdown and Restores Immune Regulation in Autoimmune Diabetes.
    Mondanelli G; Albini E; Pallotta MT; Volpi C; Chatenoud L; Kuhn C; Fallarino F; Matino D; Belladonna ML; Bianchi R; Vacca C; Bicciato S; Boon L; Ricci G; Grohmann U; Puccetti P; Orabona C
    Front Immunol; 2017; 8():428. PubMed ID: 28450863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indoleamine 2,3-dioxygenase-expressing leukemic dendritic cells impair a leukemia-specific immune response by inducing potent T regulatory cells.
    Curti A; Trabanelli S; Onofri C; Aluigi M; Salvestrini V; Ocadlikova D; Evangelisti C; Rutella S; De Cristofaro R; Ottaviani E; Baccarani M; Lemoli RM
    Haematologica; 2010 Dec; 95(12):2022-30. PubMed ID: 20801903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IDO1 promotes CSFV replication by mediating tryptophan metabolism to inhibit NF-κB signaling.
    Zhao F; Huang Y; Ji J; Liu X; Li X; Zou L; Wu K; Liu Xd; Zeng S; Wang X; Hu W; Song Y; Lu Z; Zhou B; Li P; Wang W; Zhao M; Chen J; Yi L; Fan S
    J Virol; 2024 Jul; 98(7):e0045824. PubMed ID: 38814067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells.
    Pallotta MT; Orabona C; Volpi C; Vacca C; Belladonna ML; Bianchi R; Servillo G; Brunacci C; Calvitti M; Bicciato S; Mazza EM; Boon L; Grassi F; Fioretti MC; Fallarino F; Puccetti P; Grohmann U
    Nat Immunol; 2011 Jul; 12(9):870-8. PubMed ID: 21804557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.